Why Diagnose AD Early
As the Number of People Living With Alzheimer's Disease (AD) Grows, Swift, Accurate Diagnosis Matters More Than Ever
A Timely AD Diagnosis Is Critical to Guide Patient Care, Regardless of Disease Severity1
Early Detection, Lifelong Impact: Early Diagnosis Can Enable Meaningful Lifestyle Changes for Many Patients1
Early and Accurate Detection Can Potentially Alter the Trajectory of Disease Progression With Disease-Modifying Therapy1,2,5
Symptomatic Treatment Can Help Many Patients and Caregivers Manage AD Dementia Symptoms2
Potential Care Options for Individuals Across the Clinical Stages of the AD Continuum1

An early AD diagnosis can empower patients to proactively manage their health, allowing for independent decision-making.2
1. Alzheimer’s Association. 2026 Alzheimer’s disease facts and figures. Alzheimers Dement. 2026;22. https://doi.org/10.1002/alz.71345. 2. Gauthier S, Webster C, Servaes S, Morais JA, Rosa-Neto P. World Alzheimer report 2022: life after diagnosis: navigating treatment, care and support. Alzheimer’s Disease International. Published September 2022. Accessed December 12, 2025. https://www.alzint.org/u/World-Alzheimer-Report-2022.pdf. 3. Kusoro O, Roche M, Del-Pino-Casado R, Leung P, Orgeta V. Time to Diagnosis in Dementia: A Systematic Review With Meta-Analysis. Int J Geriatr Psychiatry. 2025;40(7):e70129. 4. LEQEMBI (lecanemab-irmb) [package insert]. Nutley, NJ: Eisai Inc. 5. KISUNLA [package insert]. Eli Lilly and Company. 6. van Dyck CH, Sperling R, Li D, et al. Lecanemab for the treatment of early Alzheimer’s disease: the extension of efficacy results from CLARITY AD. Presented at the American Academy of Neurology (AAN) 2025 Annual Meeting. April 5-9, 2025. San Diego, CA.





